NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root
出版年份 2020 全文链接
标题
NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 29, Issue 2, Pages 191-196
出版商
Informa UK Limited
发表日期
2020-01-14
DOI
10.1080/13543784.2020.1715940
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial
- (2019) Anirudh Kumar et al. Diabetes & Vascular Disease Research
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Impaired skeletal muscle mitochondrial pyruvate uptake rewires glucose metabolism to drive whole-body leanness
- (2019) Arpit Sharma et al. eLife
- PNPLA3 I148M and liver fat and fibrosis scores predict liver disease mortality in the United States population
- (2019) Aynur Unalp‐Arida et al. HEPATOLOGY
- Classification of Type 2 Diabetes Genetic Variants and a Novel Genetic Risk Score Association with Insulin Clearance
- (2019) Mark O Goodarzi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis
- (2018) Jerry R. Colca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
- (2018) Pegah Golabi et al. MEDICINE
- Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture
- (2018) Domenico Accili DIABETES
- PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development
- (2018) Steven P. Tanis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis
- (2017) Kyle S. McCommis et al. HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets
- (2017) Yadan Chen et al. PPAR Research
- Basal hyperinsulinemia beyond a threshold predicts major adverse cardiac events at 1 year after coronary angiogram in type 2 diabetes mellitus: a retrospective cohort study
- (2017) Mukund Srinivasan et al. Diabetology & Metabolic Syndrome
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity
- (2017) Adam J. Rauckhorst et al. Molecular Metabolism
- Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
- (2016) Romina Lomonaco et al. DIABETES CARE
- The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health
- (2016) Mary Rinella et al. HEPATOLOGY
- Mitochondrial pyruvate transport: a historical perspective and future research directions
- (2015) Kyle S. McCommis et al. BIOCHEMICAL JOURNAL
- Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
- (2015) Jessica Bazick et al. DIABETES CARE
- The TZD insulin sensitizer clue provides a new route into diabetes drug discovery
- (2015) Jerry R. Colca Expert Opinion on Drug Discovery
- Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
- (2014) Raymond E. Soccio et al. Cell Metabolism
- Cardiovascular Health and Protection Against CVD
- (2014) Donald M. Lloyd-Jones CIRCULATION
- Mitochondrial target of thiazolidinediones
- (2014) J. R. Colca et al. DIABETES OBESITY & METABOLISM
- All-Cause and Cardiovascular Mortality in Middle-Aged People With Type 2 Diabetes Compared With People Without Diabetes in a Large U.K. Primary Care Database
- (2013) K. S. Taylor et al. DIABETES CARE
- Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases
- (2013) Jerry R Colca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
- (2013) Jerry R. Colca et al. PLoS One
- Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione
- (2012) Zhouji Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
- (2009) R. A. DeFronzo DIABETES
- Genetic Architecture of Type 2 Diabetes: Recent Progress and Clinical Implications
- (2009) R. W. Grant et al. DIABETES CARE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started